Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Brad Sorensen

2023 NFL Scouting Combine Preview: Chargers GM Tom Telesco’s testing thresholds

With the 2023 NFL Scouting Combine set to start this week, we look at the types of players that Chargers GM Tom Telesco covets.

USA Today Sports Media Group

FRXIF: A Stock On the Cusp of Catching On Fire

By Brad Sorensen, CFA OTC:FRXIF READ THE FULL FRXIF RESEARCH REPORT

Benzinga

CLMEF: An Energy Company with an Enticing Yield

By Brad Sorensen, CFA OTC:CLMEF

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

MCVT: An Old-Fashioned Money Maker in Volatile Times

By Brad Sorensen, CFA NASDAQ:MCVT

Benzinga

LGVN: Alzheimer's Study Gains Traction as CEO Search Continues

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

SPRC: Clinical-stage pharma company using cannabinoids to address serious health issues.

By Brad Sorensen, CFA NASDAQ:SPRC

Benzinga

GNS: Revolutionizing Education of All Types

By Brad Sorensen, CFA NYSE:GNS READ THE FULL GNS RESEARCH REPORT

Benzinga

Read news from The Economist, FT, and more,
with one subscription

SBFM: Working to Change the Cancer Fight

By Brad Sorensen, CFA NASDAQ:SBFM

Benzinga

LGVN: CEO Leaving but Progress Continues

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

AMTI: AMTI is Underappreciated

By Brad Sorensen, CFA NASDAQ:AMTI READ THE FULL AMTI RESEARCH REPORT

Benzinga

Sleep Apnea—A Plague for America with More Help on the Way

By Brad Sorensen, CFA OTC:RSPI | NASDAQ:IXHL

Benzinga

ENSC: Ensysce Releases Encouraging Financials

By Brad Sorensen, CFA NASDAQ:ENSC READ THE FULL ENSC RESEARCH REPORT

Benzinga

MITO: Stealth BioTherapeutics' Treatments Gain Momentum

By Brad Sorensen, CFA NASDAQ:MITO READ THE FULL MITO RESEARCH REPORT

Benzinga

LGVN: LGVN Publishes Positive Alzheimer's Results

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

EMMA: Emmaus Sickle Cell Treatment Expands Reach

By Brad Sorensen, CFA OTC:EMMA READ THE FULL EMMA RESEARCH REPORT

Benzinga

BBLG: Bone Biologics Inks Important Supply Agreement

By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT

Benzinga

LGVN: Longeveron Continues to Make Progress

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

BBLG: Back Pain Solution Potentially on the Way

By Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

LGVN: Using Cellular Technology to Ease Major Medical Issues

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

EMMA: Easing Suffering from Sickle Cell Disease

By Brad Sorensen, CFA OTC:EMMA READ THE FULL EMMA RESEARCH REPORT

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Association

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.